25 results on '"TUMOLO, S."'
Search Results
2. Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification
3. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
4. Salvage Treatment in Locoregional Recurrent Esophageal Carcinoma (EC) Using Intensity Modulated Radiation Therapy - Helical Tomotherapy (IMRT-HT)
5. Prognostic Significance of Epidermal Growth Factor Receptor Overexpression and Chromosome 7 Polysomy in Clear Cell Renal Cell Carcinoma
6. 323 Vascular Endothelial Growth Factor as Prognostic Factor in Patients with Breast Cancer. a Multicentric Long-term Follow up Study
7. 343 Risk Factors of Breast Cancer Relapse. a Case-control Study and Results of Multivariate Analysis in a Cohort of 348 Patients Who Underwent Curative Surgery
8. 6086 Induction of resectability of colorectal liver metastases (CLM) with cetuximab (Cmab) plus CPT-11/5-fluorouracil (5-FU)/leucovorin (FA)/oxaliplatin (L-OHP) (CPT-11-FFL) (POCHER trial)
9. P-764 Phase II study of topotecan plus gemcitabine in previously treated small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary Group study (ATOM 012)
10. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupAnn Oncol 2003; 14: 441–448
11. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
12. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group
13. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer
14. Elderly Ovarian Cancer: Treatment with Mitoxantrone–Carboplatin
15. Phase II study of Topotecan (T) IV with carboplatin (Carbo) in advanced NSCLC
16. Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group
17. Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma
18. Dose finding and pharmacokinetic (PK) study of daily oral Idarubicin (IDA) in metastatic breast cancer (MBC)
19. 136 P - Feasibility and activity of a 3-day pelf-like regimen in advanced gastric cancer. Preliminary data
20. Correlation between the quantitative liver function test “MEGX” and vinorelbine clearance in patients with breast cancer
21. Quantitative liver function by monoethylglycinexylidide (MEGX) test in liver metastases
22. A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
23. Prospective analysis of the information level of Italian cancer patients
24. Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group study
25. Management of AIDS and its neoplastic complications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.